Laboratory Test Preparation

| Test | : | NSE (Lung CA) |
| Other Test Request Name | : | Neuron Specific Enolase
|
| Test Composition | : | Not applicable |
| Intended Use | : | May be useful in treatment monitoring of small cell lung ca; also in brain injury like stroke, trauma epilepsy. |
| Methodology | : | Electrochemiluminescence |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
NOTE:interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplement containing biotin. Essential to STOP treatment 8 days before taking the sample.
|
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 1 Hour |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 4:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Glycolytic enzyme, small-cell lung cancer (SCLC) |
| Test | : | NST (Non-Stress Test) |
| Other Test Request Name | : |
|
| Test Composition | : | - |
| Intended Use | : | The Non Stress Test (NST) is a prenatal test that measures fetal heart rate and response to movement in the third trimester to ensure that the baby is doing well and has no problem in receiving enough oxygen because of placental or umbilical cord problems. During a non-stress test a baby's heart rate is monitored to see how it responds to the baby's movement. It is generally ordered when…
|
| Methodology | : | - |
| Laboratory Section | : | IMAGING DEPARTMENT |
| Special Instructions/Patient Preparations | : | The best time to do the procedure isafter 28 weeks (during the third trimester) of pregnancy. SCHEDULE
|
| Collection/Sample Container | : | - |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | - |
| Alternative Specimen and Volume Requirement | : | - |
| Specimen Stability | - | |
| • Room Temperature (15-25°C) | : | - |
| • Refrigerated Temperature (2-8°C) | : | - |
| • Freezer Temperature (-20°C) | : | - |
| Transport Temperature | : | - |
| Rejection Criteria | : | - |
| Running Day | : | - |
| Cut Off Time | : | - |
| TAT/Releasing of Results | : | 1 to 2 working days |
| Reference Interval/Result Interpretation | : | - |
| Limitations/Interferences | : | - |
| Frequently Asked Questions (FAQs) | : | How is NST being done?
How often the test is done during pregnancy?
What are the associated risks with the Non-Stress Test?
What to know about the test results?
|
| Related Words/Test | : | - |
| Test | : | NTproBNP |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : |
|
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Red / Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2-3 mL serum |
| Alternative Specimen and Volume Requirement | : | 2-3 mL plasma ( K2 edta, K3 Edta) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 3 days |
| • Refrigerated Temperature (2-8°C) | : | 6 days |
| • Freezer Temperature (-20°C) | : | 24 months |
| Transport Temperature | : | Specimen should be stored and transported at 2 – 8 °C (with cold packs). |
| Rejection Criteria | : |
|
| Running Day | : | Tuesday - Thursday - Saturday |
| Cut Off Time | : | 7 pm on running Day |
| TAT/Releasing of Results | : | 4 hours upon receipt of sample/ arrival of messenger |
| Reference Interval/Result Interpretation | : | AVAILABLE UPON REQUEST |
| Limitations/Interferences | : |
|
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Congestive Heart Failure, Heart Disease, Angina, Heart Attack and Acute Coronary Syndrome |
| Test | : | NTx |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | This species corresponds to the N-terminal telopeptide of Type I collagen and its level in the urine gives a measure of the rate of bone resorption. |
| Methodology | : | Enzyme-immunoassay (EIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Plastic screw cup container (sterile) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 100 mL of Random Urine |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 5 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 12:00 PM |
| TAT/Releasing of Results | : | 4 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified. |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Occult Bld(FIT)Test w/Kit |
| Other Test Request Name | : | • Hidden Blood Test • iFOBT
|
| Test Composition | : | Not applicable |
| Intended Use | : | A colorectal cancer screening test that detects if there is any hidden blood in stool. The presence of blood may be a sign of lower gastrointestinal disorders that should be treated |
| Methodology | : | Fecal Immunochemical Test (Immunochromatographic Assay) |
| Laboratory Section | : | Clinical Microscopy |
| Special Instructions/Patient Preparations | : | 1. Carefully read Instructions before beginning your specimen collection. |
| Collection/Sample Container | : | Insure FIT Collection kit |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Fecal swabs collected from 2 different surface of the stool of one time bowel movement. Instructions for use for sample collection and handling are included in the insureONE Collection Kit. |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 14 Days |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimens immediately to HPD Laboratory at room temperature (15-25°C) after the second collection. |
| Rejection Criteria | : | • Expired test card. |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday |
| TAT/Releasing of Results | : | ROUTINE |
| Reference Interval/Result Interpretation | : | NEGATIVE |
| Limitations/Interferences | : | • Patient with hemorrhoids, bleeding cuts or wounds can cause false-positive result. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | • Bleeding hemorrhoids |
| Test | : | Occult Blood (Guiac) |
| Other Test Request Name | : | • Hidden Blood Test •Stool Occult Blood •Fecal Occult Blood Test (FOBT) •Guiac Based FOBT •gFOBT
*Fecal Occult Blood Test (FOBT) *Guiac -based FOBT *Hemocult
|
| Test Composition | : | Not applicable |
| Intended Use | : | Simple, aesthetic, inexpensive test designated for use in collection and preparation of stool specimen. The positive test may result from either upper gastrointestinal bleeding or lower gastrointestinal bleeding and further investigation for peptic ulcers or a malignancy. |
| Methodology | : | Guiac Principle |
| Laboratory Section | : | Clinical Microscopy |
| Special Instructions/Patient Preparations | : | 1. Do not collect samples during or until 3 days after menstrual period or while having bleeding hemorrhoids or blood in the urine. |
| Collection/Sample Container | : | Clean, leak-proof container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Pea sized or size of 25 centavo coin stool |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 2 Hours |
| • Refrigerated Temperature (2-8°C) | : | 24 Hours |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : |
|
| Rejection Criteria | : | • Stool sample that has not met the patient preparation criteria
|
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday |
| TAT/Releasing of Results | : | ROUTINE |
| Reference Interval/Result Interpretation | : | NEGATIVE |
| Limitations/Interferences | : | • Ingestion of ascorbic acid (Vit C) in high doses has been, shown to cause false negative results. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | •Gastrointestinal diseases. |
| Test | : | Oestrone |
| Other Test Request Name | : | • Estrone • E1 |
| Test Composition | : | Not applicable |
| Intended Use | : | Estrone is both secreted by the ovary and (about 30% in females) generated by the conversion of precursors like estradiol and delta-4 androstenedione. In menstruating women, estrone levels are lower than those of estradiol but this situation is reversed following menopause when estrone becomes the predominant estrogen. Since there is no more ovarian production, all of the estrone is derived from the peripheral metabolism of delta-4 androstenedione. |
| Methodology | : | Radio Immuno Assay (RIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 4 Days |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 30 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen • Markedly lipemic specimen • Exceeded sample stability requirement • Quantity not sufficient • Improperly labeled specimen • Improper collection tube used |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Estrogenic hormone secreted by the ovary |
| Test | : | OGTT Non-Pregnant (75 gms) |
| Other Test Request Name | : | • Oral Glucose Tolerance Test |
| Test Composition | : | 1. OGTT FBS |
| Intended Use | : | • Used to support or rule out a diagnosis of diabetes mellitus |
| Methodology | : | Hexokinase |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | • 8-12 hours fasting prior to testing. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3mL Plasma (Li-heparin and K2-EDTA, NaF/Na2 EDTA, KF/Na2 EDTA, NaF/K?Oxalate and NaF/citrate/Na2?EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Serum (no hemolysis): 8 hours |
| • Refrigerated Temperature (2-8°C) | : | 72 Hours |
| • Freezer Temperature (-20°C) | : | Not specified |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday: 10:00 PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards RELEASING TIME: ROUTINE
|
| Reference Interval/Result Interpretation | : | • FBS: 3.89~5.49 mmol/L (70.10~98.93 mg/dL) |
| Limitations/Interferences | : | • The OGTT is not indicated in these situations: |
| Frequently Asked Questions (FAQs) | : | Q: When should testing for diabetes start? |
| Related Words/Test | : | Diabetes, DM |
| Test | : | OGTT-Pregnant (100 gms) |
| Other Test Request Name | : | • Oral Glucose Tolerance Test |
| Test Composition | : | 1. OGTT FBS |
| Intended Use | : | • OGTT-Pregnant (100 gms) test is used to detect gestational diabetes. |
| Methodology | : | Hexokinase |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | • 8-12 hours fasting prior to testing. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3mL Plasma (Li-heparin and K2-EDTA, NaF/Na2 EDTA, KF/Na2 EDTA, NaF/K?Oxalate and NaF/citrate/Na2?EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Serum (no hemolysis): 8 hours |
| • Refrigerated Temperature (2-8°C) | : | 72 Hours |
| • Freezer Temperature (-20°C) | : | Not specified |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday: 10:00 PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards RELEASING TIME: ROUTINE
|
| Reference Interval/Result Interpretation | : | • FBS: 3.89~5.49 mmol/L (70.10~98.93 mg/dL) |
| Limitations/Interferences | : | In very rare cases, gammopathy, in particular type IgM (Waldenstrom’s |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Diabetes, DM, Pregnancy, Gestational Diabetes |
| Test | : | OGTT-Pregnant (75 gms) |
| Other Test Request Name | : | • Oral Glucose Tolerance Test |
| Test Composition | : | 1. OGTT FBS |
| Intended Use | : | • OGTT-Pregnant (75 gms) test is used to detect gestational diabetes. |
| Methodology | : | Hexokinase |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | • 8-12 hours fasting prior to testing. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3mL Plasma (Li-heparin and K2-EDTA, NaF/Na2 EDTA, KF/Na2 EDTA, NaF/K?Oxalate and NaF/citrate/Na2?EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Serum (no hemolysis): 8 hours |
| • Refrigerated Temperature (2-8°C) | : | 72 Hours |
| • Freezer Temperature (-20°C) | : | Not specified |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday: 10:00 PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards RELEASING TIME: ROUTINE
|
| Reference Interval/Result Interpretation | : | • FBS: 3.89~5.49 mmol/L (70.10~98.93 mg/dL) |
| Limitations/Interferences | : | In very rare cases, gammopathy, in particular type IgM (Waldenstrom’s macroglobulinemia), may cause unreliable results. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Diabetes, DM, Pregnancy, Gestational Diabetes |
| Test | : | Oligoclonal Bands |
| Other Test Request Name | : |
|
| Test Composition | : | 1. Immunofixatin Electrophoresisis |
| Intended Use | : | Helps support the diagnosis of Multiple Sclerosis (MS), however it does not confirm the diagnosis. |
| Methodology | : | Hydragel Electrophoresis |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Sterile, leak proof clean container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2 mL CSF |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 24 Hours |
| • Freezer Temperature (-20°C) | : | 14 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday |
| Cut Off Time | : | Tuesday to Friday, 7:00 A.M |
| TAT/Releasing of Results | : | 7 working Days after running day (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Immunoglobulins, Multiple Sclerosis |
| Test | : | Omega 3 and Fatty Acids |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not Applicable |
| Intended Use | : | The Omega-3 Index is a measure of Omega-3 blood levels. It is the measurement of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Omega-3 fatty acids as a fraction of the total fatty acids in your red blood cells and have antiinflammatory properties. Too much inflammation or persistent inflammation at low levels is undesirable. |
| Methodology | : | Gas Chromatography |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
Collection Instructions:
Collect the sample:
|
| Collection/Sample Container | : | Omega 3 and Fatty Acids Kit will be provided by HPD Special Test Section. |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Dried Blood Spot |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 14 Days |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 15°C ~25 °C (room temperature) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 4:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : |
Q:What is the Omega-6 to Omega-3 Ratio? A:Omega-6’s are important fatty acids mainly responsible for the inflammatory response. Inflammation is important in fightinginfection and disease.Omega-6 is found in vegetable oils, cheaper margarines (and oftenused in food manufacturing pastries, pre-cooked oven bakedpotato chips), grains, seeds and nuts and reducing intake fromthese foods can help reach an optimal ratio. Lower Omega-6 to Omega-3 ratios (less than 3) have beenassociated with lower incidence of certain cancers,cardiovascular, autoimmune and inflammatory diseases. Q: What is the Arachidonic Acid (AA) to Eicosapentaenoic Acid (EPA) Ratio? A:Arachidonic acid (AA) is an Omega-6 polyunsaturated fat that is produced from the intake of vegetable oils and red meat. It is proinflammatory and plays an important role in warding off infections. Eicosapentaenoic acid (EPA) is one of the Omega-3 fatty acids and has anti-inflammatory properties and counterbalances the pro-inflammatory effects of AA. The AA/EPA ratio has been used as an indicator of cellular inflammation. An AA/EPA ratio between 1.5 and 3.0 is desirable.
|
| Related Words/Test | : | Oocosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) |
| Test | : | Opiates |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | Used as a screening test for qualitative detection of opiates in urine. |
| Methodology | : | Lateral Flow Immunochromatography (Competitive Binding) |
| Laboratory Section | : | Drug Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary |
| Collection/Sample Container | : | 60-mL clean, screw cap, polyethylene container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 60 mL urine |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not specified |
| • Refrigerated Temperature (2-8°C) | : | 48 Hours |
| • Freezer Temperature (-20°C) | : | Not specified |
| Transport Temperature | : | Not applicable |
| Rejection Criteria | : | • Incompatibility of the ID number on the specimen received by the laboratory with the number on the CCF. • Absence of ID number on the specimen • No printed Authorized Specimen Collector’s name and signature on the CCF. • Broken or tampered seal on the specimen container • Insufficient quantity of specimen, below 60 mL for single collection; below 30 mL for spilt collection |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday • 6:00 PM Sunday • 3:00 PM |
| TAT/Releasing of Results | : | ROUTINE • 3 hours after receipt of specimen/ arrival of messenger STAT • After 1½ hours from receipt of specimen/ arrival of messenger |
| Reference Interval/Result Interpretation | : | Not applicable |
| Limitations/Interferences | : | • Other drugs with the same structure with the abused drugs • Cross-reactant chemicals • Bleach or alum |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Papaver somniferum, morphine, codeine, and thebaine |
| Test | : | Organic Acid-Temporarily Unavailable (currently not accepting samples) |
| Other Test Request Name | : | Urinary Organic Acid Profile |
| Test Composition | : | Not applicable |
| Intended Use | : | Organic acidurias are a group of inborn errors of metabolism that may lead to acute life-threatening illness, developmental delays, and metabolic decompensation. Positive results may warrant confirmation by alternative specific methods. a well-established procedure for diagnosis of classical and other organic acidurias, ornithine transcarbamoylase deficienc, and fatty acid oxidation defects. |
| Methodology | : | Gas Chromatography/Mass Spectrometry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
For newborn and geriatic patients: SPLIT COLLECTION (within 12Hrs): DO NOT COLLECT SAMPLE THAT WILL FALL ON WEEKEND
|
| Collection/Sample Container | : | Plastic leak proof clean container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : |
|
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 1 Hour(for Single Collection Only) |
| • Freezer Temperature (-20°C) | : | 12 Hours(for Single and Split Collection) |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Tuesday and Thursday |
| Cut Off Time | : | Monday and Wednesday, 7:00 AM |
| TAT/Releasing of Results | : | 4 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Metabolic Analysis, gastrointestinal function, cellular and mitochondrial energy production, neurotransmitter processing, and amino acid/organic acid balance as influenced by vitamin/mineral cofactors |
| Test | : | Organic and Metabolic Scr-Temporarily Unavailable (currently not accepting samples) |
| Other Test Request Name | : | Organic Acid and Metabolic Screening |
| Test Composition | : | Not applicable |
| Intended Use | : |
Involves analysing urine to detect altered levels ofintermediate metabolites that result from incomplete metabolism of amino or organicacids. The analytical methods used to diagnose amino acid and organic acid disordersdiffer. |
| Methodology | : | Gas Chromatography/Mass Spectrometry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
For newborn and geriatic patients: SPLIT COLLECTION (within 12Hrs): DO NOT COLLECT SAMPLE THAT WILL FALL ON WEEKEND Note date and time of sample collection (each container) |
| Collection/Sample Container | : | Plastic leak proof clean container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : |
|
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 1 Hour(for Single Collection Only)
|
| • Freezer Temperature (-20°C) | : | 12 Hours(for Single and Split Collection) |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) -for Single Collection Transport specimen at -20 °C (with ice packs) -for Single and Split |
| Rejection Criteria | : |
|
| Running Day | : | Tuesday and Thursday
|
| Cut Off Time | : | Monday and Wednesday, 7:00 AM |
| TAT/Releasing of Results | : | 2 months after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Organic aciduria, metabolic disorders |